- Active not recruitingPHASE2, PHASE3
Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIV
This study looks at new ways to treat HIV in children. It's testing if certain medicines (ATV/co, DRV/co, F/TAF) are safe and work well for children aged 4 weeks to 17 years. The goal is to find better treatment options for young people living with HIV.
For: Acquired Immune Deficiency Syndrome (AIDS) · HIV InfectionsUnited States · Argentina · South Africa - Active not recruitingPHASE3
Study to Evaluate the Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Exposure Prophylaxis in Men and Transgender Women Who Have Sex With Men and Are At Risk of HIV-1 Infection
This study looks at a new daily tablet (F/TAF) for preventing HIV in men and transgender women who have sex with men and are at high risk. It compares it to an existing prevention tablet (F/TDF) to see how well they work and if they are safe.
For: Pre-Exposure Prophylaxis of HIV-1 InfectionUnited States · Austria · Canada